Search research articles
Contact Us
Filters
Showing results (51-60 of 159) with videos related to
Page
of 16
Sort By:
The Medical Journal of Australia
|
March 25, 2025
The costs and benefits of a prison needle and syringe program in Australia, 2025-30: a modelling study
Farah Houdroge, Samantha Colledge-Frisby, Nadine Kronfli, et al.
Journal of the International AIDS Society
|
January 10, 2018
Eliminating hepatitis C virus as a public health threat among HIV-positive men who have sex with men: a multi-modelling approach to understand differences in sexual risk behaviour
Nick Scott, Mark Stoové, David P Wilson, et al.
BMJ Global Health
|
January 17, 2024
Evaluation of the use of modelling in resource allocation decisions for HIV and TB
Anna L Bowring, Debra Ten Brink, Rowan Martin-Hughes, et al.
Plos One
|
June 1, 2017
Longitudinal changes in personal wellbeing in a cohort of people who inject drugs
Nick Scott, Elise R Carrotte, Peter Higgs, et al.
Epidemics
|
June 24, 2017
Optimally capturing latency dynamics in models of tuberculosis transmission
Romain Ragonnet, James M Trauer, Nick Scott, et al.
Bulletin of the World Health Organization
|
August 4, 2022
Controlled temperature chain for vaccination in low- and middle-income countries: a realist evidence synthesis
Christopher P Seaman, Anna-Lea Kahn, Debra Kristensen, et al.
Plos One
|
June 19, 2018
Hepatitis C virus notification rates in Australia are highest in socioeconomically disadvantaged areas
Samuel W Hainsworth, Paul M Dietze, David P Wilson, et al.
Journal of Viral Hepatitis
|
March 19, 2020
Measuring hepatitis C virus elimination as a public health threat: Beyond global targets
Daniela K van Santen, Rachel Sacks-Davis, Joseph S Doyle, et al.
BMC Health Services Research
|
December 19, 2025
Costing analysis of a Queensland community corrections hepatitis C screening program
Kelly Maynard, Farah Houdroge, Rachael Thompson, et al.
Alimentary Pharmacology & Therapeutics
|
March 26, 2019
Treatment access is only the first step to hepatitis C elimination: experience of universal anti-viral treatment access in Australia
Joseph S Doyle, Nick Scott, Rachel Sacks-Davis, et al.
Page
of 16
Search research articles
Search
Showing results (51-60 of 159) with videos related to
Sort By:
Page
of 16
The Medical Journal of Australia
|
March 25, 2025
The costs and benefits of a prison needle and syringe program in Australia, 2025-30: a modelling study
Farah Houdroge, Samantha Colledge-Frisby, Nadine Kronfli, et al.
Journal of the International AIDS Society
|
January 10, 2018
Eliminating hepatitis C virus as a public health threat among HIV-positive men who have sex with men: a multi-modelling approach to understand differences in sexual risk behaviour
Nick Scott, Mark Stoové, David P Wilson, et al.
BMJ Global Health
|
January 17, 2024
Evaluation of the use of modelling in resource allocation decisions for HIV and TB
Anna L Bowring, Debra Ten Brink, Rowan Martin-Hughes, et al.
Plos One
|
June 1, 2017
Longitudinal changes in personal wellbeing in a cohort of people who inject drugs
Nick Scott, Elise R Carrotte, Peter Higgs, et al.
Epidemics
|
June 24, 2017
Optimally capturing latency dynamics in models of tuberculosis transmission
Romain Ragonnet, James M Trauer, Nick Scott, et al.
Bulletin of the World Health Organization
|
August 4, 2022
Controlled temperature chain for vaccination in low- and middle-income countries: a realist evidence synthesis
Christopher P Seaman, Anna-Lea Kahn, Debra Kristensen, et al.
Plos One
|
June 19, 2018
Hepatitis C virus notification rates in Australia are highest in socioeconomically disadvantaged areas
Samuel W Hainsworth, Paul M Dietze, David P Wilson, et al.
Journal of Viral Hepatitis
|
March 19, 2020
Measuring hepatitis C virus elimination as a public health threat: Beyond global targets
Daniela K van Santen, Rachel Sacks-Davis, Joseph S Doyle, et al.
BMC Health Services Research
|
December 19, 2025
Costing analysis of a Queensland community corrections hepatitis C screening program
Kelly Maynard, Farah Houdroge, Rachael Thompson, et al.
Alimentary Pharmacology & Therapeutics
|
March 26, 2019
Treatment access is only the first step to hepatitis C elimination: experience of universal anti-viral treatment access in Australia
Joseph S Doyle, Nick Scott, Rachel Sacks-Davis, et al.
Page
of 16